A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

Cancer
Lung Cancer
Non Small Cell Lung Carcinoma

Results
Download
Print

Study results

LPS YO30157 IMpower151 Final Results April 2025 English (PDF, 0.3 MB)

LPS YO30157 IMpower151 Final Results April 2025 Chinese (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

Study results

LPS YO30157 IMpower151 Final Results April 2025 English (PDF, 0.3 MB)

LPS YO30157 IMpower151 Final Results April 2025 Chinese (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151)

For the latest version of this information please go to www.forpatients.roche.com